Front. Mol. Neurosci., 2015 · DOI: 10.3389/fnmol.2015.00027 · Published: June 16, 2015
The adult mammalian central nervous system (CNS) has a poor ability to regenerate and restore function after injury. The presence of inhibitory factors in the CNS microenvironment contributes to the failure of axons to regenerate. Myelin-associated inhibitors (MAIs) including Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte myelin glycoprotein (OMgp) collapse axonal growth cones and inhibit growth. The deposition of chondroitin sulfate proteoglycans (CSPGs) by reactive astrocytes also presents a formidable barrier to axon regeneration through sites of injury. Targeting these extrinsic inhibitory factors has led to modest improvements in axonal plasticity and functional recovery after CNS injury. The neuron-intrinsic growth state can regulate the sensitivity of the injured axon to extrinsic factors.
Development of selective antagonists to neutralize the inhibitory effect of myelin proteins may improve regeneration.
Relieving CSPG-dependent capture of growth cones can improve serotonergic axon sprouting and functional recovery after SCI.
Targeting intracellular growth regulators may drive neuron growth and relieve sensitivity to extrinsic inhibition of growth.